Literature DB >> 25421700

The IL-20 subfamily of cytokines--from host defence to tissue homeostasis.

Sascha Rutz1, Xiaoting Wang1, Wenjun Ouyang1.   

Abstract

The interleukin-20 (IL-20) subfamily of cytokines comprises IL-19, IL-20, IL-22, IL-24 and IL-26. These cytokines are all members of the larger IL-10 family, but have been grouped together to form the IL-20 subfamily based on their usage of common receptor subunits and similarities in their target-cell profiles and biological functions. Members of the IL-20 subfamily facilitate the communication between leukocytes and epithelial cells, thereby enhancing innate defence mechanisms and tissue repair processes at epithelial surfaces. In this Review, we describe the cellular sources and targets of the IL-20 subfamily cytokines, and we detail how their expression is regulated. Much of our understanding of the unique biology of this group of cytokines is still based on IL-22, which is the most studied member of the IL-20 subfamily. Nevertheless, we attempt a broader discussion of the emerging functions of IL-20 subfamily cytokines in host defence, inflammatory diseases, cancer and metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25421700     DOI: 10.1038/nri3766

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  194 in total

1.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

2.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.

Authors:  W Xu; S R Presnell; J Parrish-Novak; W Kindsvogel; S Jaspers; Z Chen; S R Dillon; Z Gao; T Gilbert; K Madden; S Schlutsmeyer; L Yao; T E Whitmore; Y Chandrasekher; F J Grant; M Maurer; L Jelinek; H Storey; T Brender; A Hammond; S Topouzis; C H Clegg; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  Ultraviolet B light stimulates interleukin-20 expression by human epithelial keratinocytes.

Authors:  David W C Hunt; Wendy A Boivin; Lindsay A Fairley; Miroslava M Jovanovic; Diane E King; Ruth A Salmon; Oliver B Utting
Journal:  Photochem Photobiol       Date:  2006 Sep-Oct       Impact factor: 3.421

4.  TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

Authors:  Mandy J McGeachy; Kristian S Bak-Jensen; Yi Chen; Cristina M Tato; Wendy Blumenschein; Terrill McClanahan; Daniel J Cua
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

Review 5.  Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.

Authors:  John Rømer; Erik Hasselager; Peder Lisby Nørby; Torben Steiniche; Jes Thorn Clausen; Knud Kragballe
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

Review 7.  IL-22, not simply a Th17 cytokine.

Authors:  Sascha Rutz; Céline Eidenschenk; Wenjun Ouyang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

8.  Lymphotoxin regulates commensal responses to enable diet-induced obesity.

Authors:  Vaibhav Upadhyay; Valeriy Poroyko; Tae-jin Kim; Suzanne Devkota; Sherry Fu; Donald Liu; Alexei V Tumanov; Ekaterina P Koroleva; Liufu Deng; Cathryn Nagler; Eugene B Chang; Hong Tang; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2012-08-26       Impact factor: 25.606

9.  High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Zhang Wen; Quan Liao; Jianguo Zhao; Ya Hu; Lei You; Zhaohui Lu; Congwei Jia; Yingxin Wei; Yupei Zhao
Journal:  Ann Surg Oncol       Date:  2013-10-17       Impact factor: 5.344

10.  Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens.

Authors:  Ansuman T Satpathy; Carlos G Briseño; Jacob S Lee; Dennis Ng; Nicholas A Manieri; Wumesh Kc; Xiaodi Wu; Stephanie R Thomas; Wan-Ling Lee; Mustafa Turkoz; Keely G McDonald; Matthew M Meredith; Christina Song; Cynthia J Guidos; Rodney D Newberry; Wenjun Ouyang; Theresa L Murphy; Thaddeus S Stappenbeck; Jennifer L Gommerman; Michel C Nussenzweig; Marco Colonna; Raphael Kopan; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2013-08-04       Impact factor: 25.606

View more
  142 in total

1.  IL-26 AMPs up the T(H)17 arsenal.

Authors:  Jacob S Lee; Daniel J Cua
Journal:  Nat Immunol       Date:  2015-09       Impact factor: 25.606

Review 2.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

3.  Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.

Authors:  Shiyang Li; Jennifer J Heller; John W Bostick; Aileen Lee; Hilde Schjerven; Philippe Kastner; Susan Chan; Zongming E Chen; Liang Zhou
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

Review 4.  Cytokines and costimulation in acute graft-versus-host disease.

Authors:  Geoffrey R Hill; Motoko Koyama
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

5.  Boosting the IL-22 response using flagellin prevents bacterial infection in cigarette smoke-exposed mice.

Authors:  B Koné; M Pérez-Cruz; R Porte; F Hennegrave; C Carnoy; P Gosset; F Trottein; J-C Sirard; M Pichavant; P Gosset
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

6.  Murine astrocytes are responsive to the pro-inflammatory effects of IL-20.

Authors:  Amanda R Burmeister; M Brittany Johnson; Ian Marriott
Journal:  Neurosci Lett       Date:  2019-06-22       Impact factor: 3.046

7.  AMPK/HuR-Driven IL-20 Post-Transcriptional Regulation in Psoriatic Skin.

Authors:  Geneviève Garcin; Isabelle Guiraud; Matthieu Lacroix; Clémence Genthon; Stéphanie Rialle; Jean-Marie Joujoux; Laurent Meunier; Thierry Lavabre-Bertrand; Pierre-Emmanuel Stoebner; Lionel Le Gallic
Journal:  J Invest Dermatol       Date:  2015-06-15       Impact factor: 8.551

Review 8.  Trial Watch: Toll-like receptor agonists in cancer immunotherapy.

Authors:  Melody Smith; Elena García-Martínez; Michael R Pitter; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

9.  Role of oncostatin M in the pathogenesis of vernal keratoconjunctivitis: focus on tissue remodeling.

Authors:  Keitaro Mashimo; Ayumi Usui-Ouchi; Yousuke Ito; Rei Wakasa-Arai; Norihiko Yokoi; Satoshi Kawasaki; Akira Murakami; Akira Matsuda; Nobuyuki Ebihara
Journal:  Jpn J Ophthalmol       Date:  2021-01-06       Impact factor: 2.447

10.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.